Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.55% Nasdaq Up0.66%

Celgene Corporation (CELG)

-NasdaqGS

130.49 Up 0.82(0.64%) 12:57PM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 5,506,713   4,842,070   3,625,745  
Cost of Revenue299,124  425,859  306,521  
Gross Profit 5,207,589   4,416,211   3,319,224  
Operating Expenses
Research Development1,724,156  1,600,264  1,128,495  
Selling General and Administrative1,542,492  1,083,968  997,863  
Non Recurring -   -   -  
Others194,499  289,226  203,231  
Total Operating Expenses -   -   -  
Operating Income or Loss 1,746,442   1,442,753   989,635  
Income from Continuing Operations
Total Other Income/Expenses Net(1,746)19,506  35,609  
Earnings Before Interest And Taxes1,744,696  1,462,259  1,025,244  
Interest Expense63,205  42,737  12,634  
Income Before Tax1,681,491  1,419,522  1,012,610  
Income Tax Expense225,311  102,066  132,418  
Minority Interest -  694  320  
Net Income From Continuing Ops1,456,180  1,318,150  880,512  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 1,456,180   1,318,150   880,512  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 1,456,180   1,318,150   880,512  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.